Evaxion Biotech A/S(NASDAQ:EVAX) 
Evaxion Biotech A/S, a clinical-stage artificial intelligence-immunology platform company, identifies and develops novel immunotherapies for the treatment of various cancers, bacterial diseases, and viral infections. The company develops therapies using PIONEER, an immuno-oncology platform; EDEN, a ...
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 1.63
H 1.64
L 1.50
C 1.51
V 65,947
10EMA 1.51
20EMA 1.51
60EMA 1.51
120EMA 1.51
250EMA 1.51